Cover Image
Market Research Report

Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecast to 2023

Published by MarketsandMarkets Product code 743972
Published Content info 123 Pages
Delivery time: 1-2 business days
Price
Back to Top
Pacemakers Market by Implantability (External), Technology (Single Chamber, Dual Chamber, CRT-P/Biventricular Pacemaker), Type (Conventional, MRI Compatible), End User (Hospitals and Cardiac Centers, Ambulatory Surgical Center) - Global Forecast to 2023
Published: November 5, 2018 Content info: 123 Pages
Description

"Increasing prevalence of cardiovascular diseases is expected to drive the overall growth of the pacemakers market."

The pacemakers market is projected to reach USD 4.9 billion by 2023 from USD 4.4 billion in 2018, at a CAGR of 2.0%. The pacemakers market is driven by various factors such by increasing prevalence of cardiovascular diseases and technological advancements in devices. However, the high cost of pacemakers and an unfavorable reimbursement scenario are expected to limit market growth to a certain extent.

"The dual-chamber pacemakers segment is expected to grow at a higher CAGR during the forecast period."

The dual-chamber pacemakers are the faster-growing segment in the pacemakers market, by technology. The pacemakers market, by technology, has been categorized into single-chamber pacemakers, dual-chamber, and biventricular/CRT pacemakers. Dual-chamber pacemakers are the most popular of all pacemaker technologies in the market, due to the higher efficiency and cost-effectiveness of dual-chamber pacemakers in atrioventricular block or sick sinus syndrome.

"The hospitals & cardiac centers, by end user, is projected to hold the largest market share during the forecast period."

This segment includes both government and private hospitals and cardiac centers that provide treatment to patients with cardiac diseases. A number of factors, such as the increasing prevalence of cardiovascular diseases and the subsequent increase in the number of surgical procedures performed, improving healthcare infrastructure, and favorable reimbursement scenario are driving the growth of the pacemakers market for hospitals & cardiac centers.

"Asia Pacific is expected to record the highest growth rate during the forecast period."

The Asia Pacific pacemakers market, particularly in China, Japan, India, is expected to witness high growth in the next five years. This can largely be attributed to the increasing prevalence of CVDs in these countries due to various factors such as increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking

In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the pacemakers market.

  • By Company Type: Tier 1: 45%, Tier 2: 34%, and Tier 3: 21%
  • By Designation: C-level Executives: 14%, Directors: 10%, and Others: 76%
  • By Region: North America: 32%, Europe: 35%, APAC: 25%, and RoW: 8%

The pacemakers market comprises major providers such Medtronic (Ireland), Abbott (US), and Boston Scientific (US), BIOTRONIK (Germany), LivaNova (UK), OSCOR (US), Pacetronix (India), MEDICO (Italy), Osypka Medical (Germany), and Lepu Medical (China). The study includes an in-depth competitive analysis of these key players in the pacemakers market, along with their company profiles, recent developments, and key market strategies.

Research Coverage:

The market study covers the pacemakers market across various segments. It aims at estimating the market size and the growth potential of this market across different segments, on the basis of type, technology, implantability, end user, and region. The study also includes an in-depth competitive analysis of the key players in the market; along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pacemakers market and its subsegments. This report will help the stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and will provide them with information on key market drivers, restraints, challenges, and opportunities.

Table of Contents
Product Code: MD 6726

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS COVERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. PRIMARY DATA
      • 2.1.1.1. Key data from primary sources
    • 2.1.2. SECONDARY DATA
      • 2.1.2.1. Key data from secondary sources
  • 2.2. MARKET ESTIMATION METHODOLOGY
    • 2.2.1. PRIMARY RESEARCH VALIDATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS FOR THE STUDY
  • 2.5. LIMITATIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. PACEMAKERS: MARKET OVERVIEW
  • 4.2. PACEMAKERS MARKET: GEOGRAPHICAL SNAPSHOT
  • 4.3. PACEMAKERS MARKET, BY TECHNOLOGY (2018-2023)
  • 4.4. ASIA PACIFIC: PACEMAKERS MARKET, BY TECHNOLOGY (2017)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing burden of CVD
      • 5.2.1.2. Technological advancements
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of pacemakers, unfavorable reimbursement scenario
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Emerging markets
      • 5.2.3.2. Implantable micropacemakers designed for fetal use
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Shortage of cardiac surgeons
      • 5.2.4.2. Frequent product recalls

6. PACEMAKERS MARKET, BY IMPLANTABILITY

  • 6.1. INTRODUCTION
    • 6.1.1. IMPLANTABLE PACEMAKERS
      • 6.1.1.1. Introduction of leadless, miniaturized implantable pacemakers to boost segment popularity
    • 6.1.2. EXTERNAL PACEMAKER
      • 6.1.2.1. North America to lead the external pacemakers market during the forecast period

7. PACEMAKERS MARKET, BY TECHNOLOGY

  • 7.1. INTRODUCTION
    • 7.1.1. DUAL-CHAMBER PACEMAKERS
      • 7.1.1.1. Dual-chamber pacemakers are the most popular of all pacemaker technologies in the market
    • 7.1.2. SINGLE-CHAMBER PACEMAKERS
      • 7.1.2.1. The advent of leadless pacemakers will stimulate demand in this product segment
    • 7.1.3. BIVENTRICULAR/CRT PACEMAKERS
      • 7.1.3.1. North America is the largest market for biventricular/CRT pacemakers

8. PACEMAKERS MARKET, BY TYPE

  • 8.1. INTRODUCTION
    • 8.1.1. MRI COMPATIBLE PACEMAKERS
      • 8.1.1.1. Technological advancement is driving the growth of MRI Compatible pacemakers
    • 8.1.2. CONVENTIONAL PACEMAKERS
      • 8.1.2.1. Increasing aging population is a major factor driving the growth of the conventional pacemaker market

9. PACEMAKERS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS & CARDIAC CENTERS
    • 9.2.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES
  • 9.3. AMBULATORY SURGICAL CENTERS
    • 9.3.1. INCREASING NUMBER OF ASCS IN THE US

10. PACEMAKERS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. US
      • 10.2.1.1. Rising prevalence of CVDs and technological advancements in pacemakers are the major factors driving market growth
    • 10.2.2. CANADA
      • 10.2.2.1. Rising prevalence of CVDs and growing geriatric population are driving the growth of the Canadian pacemakers market
  • 10.3. EUROPE
    • 10.3.1. GERMANY
      • 10.3.1.1. Germany is expected to account for the largest share of European pacemakers market in 2018
    • 10.3.2. FRANCE
      • 10.3.2.1. Favorable insurance system is driving the growth of the French pacemakers market
    • 10.3.3. UK
      • 10.3.3.1. Technological advancements in pacemaker devices to drive the demand for pacemakers in the country
    • 10.3.4. REST OF EUROPE
  • 10.4. ASIA PACIFIC
    • 10.4.1. JAPAN
      • 10.4.1.1. MRI Compatible pacemakers have huge growth potential in Japan
    • 10.4.2. CHINA
      • 10.4.2.1. Increasing prevalence of CVDs is driving the growth of the pacemakers market in China
    • 10.4.3. INDIA
      • 10.4.3.1. Increasing pacemaker implantation procedures in India to propel market growth
    • 10.4.4. REST OF ASIA PACIFIC (ROAPAC)
  • 10.5. REST OF THE WORLD

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. PACEMAKERS MARKET SHARE ANALYSIS
  • 11.3. COMPETITIVE SITUATION AND TRENDS
    • 11.3.1. PRODUCT LAUNCHES
    • 11.3.2. COLLABORATIONS
    • 11.3.3. EXPANSIONS
    • 11.3.4. MERGERS & ACQUISITIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. MEDTRONIC
  • 12.2. ABBOTT LABORATORIES
  • 12.3. BOSTON SCIENTIFIC
  • 12.4. BIOTRONIK
  • 12.5. LIVANOVA
  • 12.6. LEPU MEDICAL
  • 12.7. SHREE PACETRONIX
  • 12.8. OSYPKA MEDICAL
  • 12.9. MEDICO SPA
  • 12.10. OSCOR

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. DISCUSSION GUIDE
  • 13.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3. AVAILABLE CUSTOMIZATIONS
  • 13.4. RELATED REPORTS
  • 13.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: CONVENTIONAL VS. MRI COMPATIBLE PACEMAKERS: PRICE LIST
  • TABLE 2: LIST OF PRODUCT RECALLS
  • TABLE 3: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 4: IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 5: NORTH AMERICA: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 6: EUROPE: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 7: ASIA PACIFIC: IMPLANTABLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 8: EXTERNAL PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 9: NORTH AMERICA: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 10: EUROPE: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: ASIA PACIFIC: EXTERNAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 12: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 13: DUAL-CHAMBER PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS
  • TABLE 14: DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 15: NORTH AMERICA: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 16: EUROPE: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: ASIA PACIFIC: DUAL-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 18: SINGLE-CHAMBER PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS
  • TABLE 19: SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 20: NORTH AMERICA: SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: EUROPE: SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 22: ASIA PACIFIC: SINGLE-CHAMBER PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: BIVENTRICULAR/CRT PACEMAKERS: KEY MANUFACTURERS AND PRODUCTS
  • TABLE 24: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 25: NORTH AMERICA: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: EUROPE: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: ASIA PACIFIC: BIVENTRICULAR/CARDIAC RESYNCHRONIZATION THERAPY PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: MRI COMPATIBLE PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 30: NORTH AMERICA: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: EUROPE: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: ASIA PACIFIC: MRI COMPATIBLE PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: CONVENTIONAL PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 34: NORTH AMERICA: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: EUROPE: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: ASIA PACIFIC: CONVENTIONAL PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 38: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 39: NORTH AMERICA: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: EUROPE: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: ASIA PACIFIC: PACEMAKERS MARKET FOR HOSPITALS & CARDIAC CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 43: NORTH AMERICA: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: EUROPE: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 45: ASIA PACIFIC: PACEMAKERS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: PACEMAKERS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 47: PACEMAKERS MARKET, BY REGION, 2016-2023 (THOUSAND UNITS)
  • TABLE 48: NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: NORTH AMERICA: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (THOUSAND UNITS)
  • TABLE 50: NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 51: NORTH AMERICA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 52: NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 53: NORTH AMERICA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 54: CLINICAL TRAILS RELATED TO PACEMAKERS IN THE US
  • TABLE 55: US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 56: US: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 57: US: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: US: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 59: CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 60: CANADA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 61: CANADA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 62: CANADA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 63: EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 64: EUROPE: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (THOUSAND UNITS)
  • TABLE 65: EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 66: EUROPE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 67: EUROPE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 68: EUROPE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 69: GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 70: GERMANY: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 71: GERMANY: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: GERMANY: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 73: FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 74: FRANCE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 75: FRANCE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: FRANCE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 77: UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 78: UK: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 79: UK: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 80: UK: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 81: ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 82: ROE: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 83: ROE: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: ROE: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 85: APAC: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 86: APAC: PACEMAKERS MARKET, BY COUNTRY, 2016-2023 (THOUSAND UNITS)
  • TABLE 87: APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 88: APAC: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 89: APAC: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: ASIA PACIFIC: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 91: JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 92: JAPAN: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 93: JAPAN: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: JAPAN: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 95: CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 96: CHINA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 97: CHINA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 98: CHINA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 99: INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 100: INDIA: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 101: INDIA: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: INDIA: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 103: ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 104: ROAPAC: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 105: ROAPAC: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 106: ROAPAC: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 107: ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2023 (USD MILLION)
  • TABLE 108: ROW: PACEMAKERS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 109: ROW: PACEMAKERS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: ROW: PACEMAKERS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 111: PRODUCT LAUNCHES, 2015 TO 2018
  • TABLE 112: COLLABORATIONS AND AGREEMENTS 2015-2018
  • TABLE 113: EXPANSIONS, 2015 TO 2018
  • TABLE 114: MERGERS & ACQUISITIONS, 2015-2018

LIST OF FIGURES

  • FIGURE 1: PACEMAKERS MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARIES
  • FIGURE 4: MARKET ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION
  • FIGURE 7: PACEMAKERS MARKET, BY IMPLANTABILITY, 2018 VS. 2023 (USD MILLION)
  • FIGURE 8: PACEMAKERS MARKET, BY TYPE, 2018 VS. 2023 (USD MILLION)
  • FIGURE 9: PACEMAKERS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE PACEMAKERS MARKET
  • FIGURE 11: INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES-MAJOR FACTOR DRIVING MARKET GROWTH
  • FIGURE 12: US ACCOUNTED FOR THE LARGEST SHARE OF THE PACEMAKERS MARKET IN 2017
  • FIGURE 13: DUAL-CHAMBER PACEMAKERS TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 14: DUAL-CHAMBER PACEMAKERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC PACEMAKERS MARKET IN 2017
  • FIGURE 15: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: PACEMAKER MARKET
  • FIGURE 16: NORTH AMERICA: PACEMAKERS MARKET SNAPSHOT
  • FIGURE 17: INCIDENCE OF CVD, IHD, AND STROKE IN GERMANY, 2015
  • FIGURE 18: ASIA PACIFIC: PACEMAKERS MARKET SNAPSHOT
  • FIGURE 19: MEDTRONIC: COMPANY SNAPSHOT (2018)
  • FIGURE 20: ABBOTT LABORATORIES : COMPANY SNAPSHOT (2017)
  • FIGURE 21: BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2017)
  • FIGURE 22: LIVANOVA : COMPANY SNAPSHOT (2017)
  • FIGURE 23: LEPU MEDICAL: COMPANY SNAPSHOT (2016)
  • FIGURE 24: SHREE PACETRONIX: COMPANY SNAPSHOT (2017)
Back to Top